These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7862457)

  • 1. Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved.
    Wang Y; Farmer G; Soussi T; Prives C
    Oncogene; 1995 Feb; 10(4):779-84. PubMed ID: 7862457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
    Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
    Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein.
    Bessard AC; Garay E; Lacronique V; Legros Y; Demarquay C; Houque A; Portefaix JM; Granier C; Soussi T
    Oncogene; 1998 Feb; 16(7):883-90. PubMed ID: 9484779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel DNA binding of p53 mutants and their role in transcriptional activation.
    Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB
    Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53.
    Abarzúa P; LoSardo JE; Gubler ML; Neri A
    Cancer Res; 1995 Aug; 55(16):3490-4. PubMed ID: 7627952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
    Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
    Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants.
    Deb D; Scian M; Roth KE; Li W; Keiger J; Chakraborti AS; Deb SP; Deb S
    Oncogene; 2002 Jan; 21(2):176-89. PubMed ID: 11803461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenopus p53 is biochemically similar to the human tumour suppressor protein p53 and is induced upon DNA damage in somatic cells.
    Cox LS; Midgley CA; Lane DP
    Oncogene; 1994 Oct; 9(10):2951-9. PubMed ID: 8084598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
    Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
    Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.
    Maruyama R; Aoki F; Toyota M; Sasaki Y; Akashi H; Mita H; Suzuki H; Akino K; Ohe-Toyota M; Maruyama Y; Tatsumi H; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2006 May; 66(9):4574-83. PubMed ID: 16651407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct regions of p53 have a differential role in transcriptional activation and repression functions.
    Sang BC; Chen JY; Minna J; Barbosa MS
    Oncogene; 1994 Mar; 9(3):853-9. PubMed ID: 8108128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of canine p53 cDNA and detailed characterization of the full length canine p53 protein.
    Veldhoen N; Milner J
    Oncogene; 1998 Feb; 16(8):1077-84. PubMed ID: 9519881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
    Di Como CJ; Prives C
    Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
    Suzuki T; Uchida-Toita M; Yoshida M
    Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV40 T antigen abrogates p53-mediated transcriptional activity.
    Jiang D; Srinivasan A; Lozano G; Robbins PD
    Oncogene; 1993 Oct; 8(10):2805-12. PubMed ID: 8378089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.